全文获取类型
收费全文 | 26537篇 |
免费 | 1359篇 |
国内免费 | 222篇 |
专业分类
耳鼻咽喉 | 269篇 |
儿科学 | 420篇 |
妇产科学 | 241篇 |
基础医学 | 3174篇 |
口腔科学 | 497篇 |
临床医学 | 1580篇 |
内科学 | 7567篇 |
皮肤病学 | 564篇 |
神经病学 | 1861篇 |
特种医学 | 1009篇 |
外科学 | 4836篇 |
综合类 | 108篇 |
一般理论 | 4篇 |
预防医学 | 707篇 |
眼科学 | 605篇 |
药学 | 1751篇 |
中国医学 | 72篇 |
肿瘤学 | 2853篇 |
出版年
2023年 | 169篇 |
2022年 | 308篇 |
2021年 | 695篇 |
2020年 | 395篇 |
2019年 | 543篇 |
2018年 | 581篇 |
2017年 | 476篇 |
2016年 | 598篇 |
2015年 | 597篇 |
2014年 | 795篇 |
2013年 | 1008篇 |
2012年 | 1557篇 |
2011年 | 1747篇 |
2010年 | 1003篇 |
2009年 | 810篇 |
2008年 | 1332篇 |
2007年 | 1576篇 |
2006年 | 1478篇 |
2005年 | 1467篇 |
2004年 | 1370篇 |
2003年 | 1279篇 |
2002年 | 1342篇 |
2001年 | 567篇 |
2000年 | 560篇 |
1999年 | 534篇 |
1998年 | 318篇 |
1997年 | 288篇 |
1996年 | 249篇 |
1995年 | 195篇 |
1994年 | 177篇 |
1993年 | 166篇 |
1992年 | 411篇 |
1991年 | 353篇 |
1990年 | 359篇 |
1989年 | 335篇 |
1988年 | 304篇 |
1987年 | 306篇 |
1986年 | 292篇 |
1985年 | 230篇 |
1984年 | 164篇 |
1983年 | 154篇 |
1982年 | 66篇 |
1981年 | 74篇 |
1980年 | 53篇 |
1979年 | 122篇 |
1978年 | 59篇 |
1977年 | 63篇 |
1974年 | 56篇 |
1973年 | 62篇 |
1972年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Seven patients with advanced lateral oropharyngeal cancer (T3N2bM0, or T4N2bM0) underwent transoral lateral oropharyngectomy (TLO) with reconstruction performed through set-back tongue flap and polyglycolic acid (PGA) sheet. TLO was performed following en bloc resection of tumors using endoscopy. To cover the resulting defect in the lateral oropharyngeal wall, the set-back tongue flap was moved posteriorly and laterally to the area of the tongue base and lateral pharyngeal wall. The tip of the set-back tongue flap was sutured to the lateral pharynx to reconstruct the elevated tongue base and altered anterior pillar. The defect on the floor of the mouth was reconstructed using a PGA sheet. Following surgery, the mean observation period was 24 months. The mean operating time was 4 h and 2 min, with an average blood loss of 68.1 ml. All oral intake resumed on the first postoperative day via gastric tube. The mean gastric tube removal time was 1.6 postoperative days as a result of sufficient oral intake. None of the patients received postoperative radiotherapy or displayed evidence of tumor recurrence. We conclude that this novel procedure is highly effective for treating advanced oropharyngeal cancer as it demonstrates good prognostic and functional outcomes. 相似文献
3.
4.
Yosuke Homma Takashi Shiga Hiraku Funakoshi Dai Miyazaki Atsushi Sakurai Yoshio Tahara Ken Nagao Naohiro Yonemoto Arino Yaguchi Naoto Morimura 《The American journal of emergency medicine》2019,37(2):241-248
Objective
This study assessed the association between the timing of first epinephrine administration (EA) and the neurological outcomes following out-of-hospital cardiac arrests (OHCAs) with both initial shockable and non-shockable rhythms.Methods
This was a post-hoc analysis of a multicenter prospective cohort study (SOS-KANTO 2012), which registered OHCA patients in the Kanto region of Japan from January 2012 to March 2013. We included consecutive adult OHCA patients who received epinephrine. The primary result included 1-month favorable neurological outcomes defined as cerebral performance category (CPC) 1 or 2. Secondary results included 1-month survival and return of spontaneous circulation (ROSC) after arrival at the hospital. Multivariable logistic regression analysis determined the association between delay per minute of the time from call to first EA in both pre- or in-hospital settings and outcomes.Results
Of the 16,452 patients, 9344 were eligible for our analyses. In univariable analysis, the delay in EA was associated with decreased favorable neurological outcomes only when the initial rhythm was a non-shockable rhythm. In multivariable analyses, delay in EA was associated with decreased ROSC (adjusted odds ratio [OR] for one minute delay, 0.97; 95% confidence interval [CI], 0.96–0.98) and 1-month survival (adjusted OR, 0.95; 95% CI, 0.92–0.97) when the initial rhythm was a non-shockable rhythm, whereas during a shockable rhythm, delay in EA was not associated with decreased ROSC and 1-month survival.Conclusions
While assessing the effectiveness of epinephrine for OHCA, we should consider the time-limited effects of epinephrine. Additionally, consideration of early EA based on the pathophysiology is needed. 相似文献5.
6.
7.
Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. 总被引:5,自引:0,他引:5
Sadao Takahashi Toshiya Tanaka Tatsuhiko Kodama Juro Sakai 《Pharmacological research》2006,53(6):501-507
The development of new treatments for metabolic syndrome is urgent project for decreasing the prevalence of coronary heart disease and diabetes mellitus in the advanced countries. Peroxisome proliferator-activated receptor (PPAR)alpha and gamma agonists have shed light on the treatment of hypertriglyceridemia and type 2 diabetes mellitus, respectively. Among PPARs, analysis of the PPARdelta functions is lagging behind because specific PPARdelta agonists have not been developed. The appearance of new PPARdelta agonists is brightening the prospects for elucidating the physiological role of PPARdelta. PPARdelta is a new target for the treatment of metabolic syndrome. In particular, the fact that fatty acid oxidation and energy dissipation in skeletal muscle and adipose tissue by PPARdelta agonists lead to improved lipid profile, reduced adiposity and insulin sensitivity is a breakthrough. It seems that treatment of PPARdelta agonists operate similarly to the caloric restriction and prolonged exercise. We suggest that the physiological role of PPARdelta may be an indicator for switching from glucose metabolism to fatty acid metabolism. To receive new benefits of PPARdelta agonists against metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue, we need to unveil more details on the functions of PPARdelta itself and its agonists in the future. 相似文献
8.
Takao Itoi Atsushi Sofuni Fumihide Itokawa Yasushi Shinohara Kazuya Takeda Kazuto Nakamura Toshio Kurihara Takayoshi Tsuchiya Fuminori Moriyasu 《Digestive endoscopy》2006,18(3):232-238
We describe our methods and outcomes of multidisciplinary treatments in patients with unresectable hilar cholangiocarcinoma. Fifty‐seven patients with a known outcome were enrolled. Thirty‐four of 57 patients were treated and evaluated by salvage therapy. For salvage therapy, we used internal and external radiotherapy, photodynamic therapy, YAG laser therapy and microwave coagulation therapy. The median survival time was 548 days for the group receiving salvage therapy and 198 days for the group not receiving this treatment. In conclusion, although no randomization of the patients was performed in this retrospective study, our present data provide convincing evidence that salvage therapy is a useful therapeutic approach for unresectable hilar cholangiocarcinomas. 相似文献
9.
10.